FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Iva Gunnarsson

Research Profile

Disorders

Procedures

Case Control Studies

Physiology

Genes & Molecular Sequences

Geographic Areas

Sweden

Chemicals & Drugs

Concepts & Ideas

Cohort Studies

Anatomy

B-Lymphocytes

Co-author Network

Publications

TOP 3
Emeli Lundström; Gunnel Nordmark; Leonid Padyukov; Lars Rönnblom; Johanna K Sandling; Gunnar Sturfelt; Ulf Sundin; Anders A Bengtsson; Kerstin Elvin; Iva Gunnarsson; Johanna T Gustafsson; Andreas Jönsen; Henrik Källberg; Lars Klareskog; Dag Leonard; Ann-Christine Syvänen; Agneta Zickert; Elisabet Svenungsson
HLA-DRB1*04/*13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus.
Thórunn Jónsdóttir; Birgitta Sundelin; Ronald F van Vollenhoven; Agneta Zickert; Elisabet W Henriksson; Iva Gunnarsson
Long-term follow-up in lupus nephritis patients treated with rituximab--clinical and histopathological response.
M Kvarnström; Lars Ottosson; Elisabet Svenungsson; V Dzikaite-Ottosson; Iva Gunnarsson; J T Gustafsson; Marie Wahren-Herlenius
Autoantibodies to the functionally active RING-domain of Ro52/SSA are associated with disease activity in patients with lupus.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Iva Gunnarsson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Emeli Lundström; Gunnel Nordmark; Leonid Padyukov; Lars Rönnblom; Johanna K Sandling; Gunnar Sturfelt; Ulf Sundin; Anders A Bengtsson; Kerstin Elvin; Iva Gunnarsson; Johanna T Gustafsson; Andreas Jönsen; Henrik Källberg; Lars Klareskog; Dag Leonard; Ann-Christine Syvänen; Agneta Zickert; Elisabet Svenungsson
HLA-DRB1*04/*13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus.
Annals of the rheumatic diseases 2013;72(6):1018-25.
2013: Thórunn Jónsdóttir; Birgitta Sundelin; Ronald F van Vollenhoven; Agneta Zickert; Elisabet W Henriksson; Iva Gunnarsson
Long-term follow-up in lupus nephritis patients treated with rituximab--clinical and histopathological response.
Rheumatology (Oxford, England) 2013;52(5):847-55.
2013: M Kvarnström; Lars Ottosson; Elisabet Svenungsson; V Dzikaite-Ottosson; Iva Gunnarsson; J T Gustafsson; Marie Wahren-Herlenius
Autoantibodies to the functionally active RING-domain of Ro52/SSA are associated with disease activity in patients with lupus.
Lupus 2013;22(5):477-85.
2013: Anna Vikerfors; Agneta Zickert; Anders Bengtsson; Kerstin Elvin; Iva Gunnarsson; Johanna T Gustafsson; Anna-Britta Johansson; Andreas Jönsen; Dag Leonard; Gunnel Nordmark; Lars Rönnblom; Gunnar Sturfelt; Elisabet Svenungsson
Clinical manifestations and anti-phospholipid antibodies in 712 patients with systemic lupus erythematosus: evaluation of two diagnostic assays.
Rheumatology (Oxford, England) 2013;52(3):501-9.
2013: Iva Gunnarsson; T Jonsdottir
Rituximab treatment in lupus nephritis--where do we stand?
Lupus 2013;22(4):381-9.
2013: I Parodis; M Axelsson; Iva Gunnarsson
Belimumab for systemic lupus erythematosus: a practice-based view.
Lupus 2013;22(4):372-80.
2012: Iva Gunnarsson; Ronald F van Vollenhoven
Biologicals for the treatment of systemic lupus erythematosus?
Annals of medicine 2012;44(3):225-32.
2012: Iva Gunnarsson; Wolfgang Schlumberger; Johan Rönnelid
Antibodies to M-type phospholipase A2 receptor (PLA2R) and membranous lupus nephritis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2012;59(4):585-6.
2012: Johanna T Gustafsson; Lars-Olof Hansson; Anders Larsson; Ingrid E Lundberg; Julia F Simard; Kerstin Elvin; Iva Gunnarsson; Elisabet Svenungsson
Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study.
Arthritis research & therapy 2012;14(2):R46.
2012: Agneta Zickert; Annette Bruchfeld; Sangeeta Chavan; Karin Palmblad; Birgitta Sundelin; Kevin J Tracey; Iva Gunnarsson
Renal expression and serum levels of high mobility group box 1 protein in lupus nephritis.
Arthritis research & therapy 2012;14(1):R36.
2011: Antoine Sreih; Lakshman Subrahmanyan; Elisabet Svenungsson; Geraldine Yu; Lin Zhang; Anna-Karin Abelson; Marta E Alarcón-Riquelme; Joshua Cavett; Rana Ezzeddine; Stuart Glenn; Iva Gunnarsson; John B Harley; Avery LaChance; Lin Leng; Yuka Mizue; Ruth Montgomery; Andras Perl; Bernardo A Pons-Estel; Jane Salmon; Richard Bucala
Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus.
Arthritis and rheumatism 2011;63(12):3942-51.
2011: Johanna K Sandling; Sophie Garnier; Snaevar Sigurdsson; Chuan Wang; Gunnel Nordmark; Iva Gunnarsson; Elisabet Svenungsson; Leonid Padyukov; Gunnar Sturfelt; Andreas Jönsen; Anders A Bengtsson; Lennart Truedsson; Catharina Eriksson; Solbritt Rantapää-Dahlqvist; Anders Mälarstig; Rona J Strawbridge; Anders Hamsten; Lindsey A Criswell; Robert R Graham; timothy wayne behrens; Maija-Leena Eloranta; Gunnar V Alm; Lars Rönnblom; Ann-Christine Syvänen
A candidate gene study of the type I interferon pathway implicates IKBKE and IL8 as risk loci for SLE.
European journal of human genetics : EJHG 2011;19(4):479-84.
2011: Andreas Jönsen; Sara C Nilsson; Gunnel Nordmark; Lars Rönnblom; Gunnar Sturfelt; Elisabet Svenungsson; Lennart Truedsson; Agneta Zickert; Emma Ahlqvist; Anders Bengtsson; Maija-Leena Eloranta; Karin G Eriksson; Iva Gunnarsson; Anna M Blom
Mutations in genes encoding complement inhibitors CD46 and CFH affect the age at nephritis onset in patients with systemic lupus erythematosus.
Arthritis research & therapy 2011;13(6):R206.
2011: Annette Bruchfeld; Mårten Wendt; Johan Bratt; Abdul Rashid Qureshi; Sangeeta Chavan; Kevin Tracey; Karin Palmblad; Iva Gunnarsson
High-mobility group box-1 protein (HMGB1) is increased in antineutrophilic cytoplasmatic antibody (ANCA)-associated vasculitis with renal manifestations.
Molecular medicine (Cambridge, Mass.) 2011;17(1-2):29-35.
2010: Susanne Pettersson; Sonia Möller; Elisabet Svenungsson; Iva Gunnarsson; Elisabet Welin Henriksson
Women's experience of SLE-related fatigue: a focus group interview study.
Rheumatology (Oxford, England) 2010;49(10):1935-42.
2010: Helga Kristjansdottir; Kristjan Steinsson; Iva Gunnarsson; Gerdur Gröndal; Kristjan Erlendsson; Marta E Alarcón-Riquelme
Lower expression levels of the programmed death 1 receptor on CD4+CD25+ T cells and correlation with the PD-1.3A genotype in patients with systemic lupus erythematosus.
Arthritis and rheumatism 2010;62(6):1702-11.
2010: Mai Tuyet Vuong; Iva Gunnarsson; Sigrid Lundberg; Elisabet Svenungsson; Lars Wramner; Anders Fernström; Ann-Christine Syvänen; Lieu Thi Do; Stefan H Jacobson; Leonid Padyukov
Genetic risk factors in lupus nephritis and IgA nephropathy--no support of an overlap.
PloS one 2010;5(5):e10559.
2009: Danika Schepis; Iva Gunnarsson; Maija-Leena Eloranta; Jon Lampa; Stefan H Jacobson; Klas Kärre; Louise Berg
Increased proportion of CD56bright natural killer cells in active and inactive systemic lupus erythematosus.
Immunology 2009;126(1):140-6.
2008: Snaevar Sigurdsson; Gunnel Nordmark; Sophie Garnier; Elin Grundberg; Tony Kwan; Olof Nilsson; Maija-Leena Eloranta; Iva Gunnarsson; Elisabet Svenungsson; Gunnar Sturfelt; Anders A Bengtsson; Andreas Jönsen; Lennart Truedsson; Solbritt Rantapää-Dahlqvist; Catharina Eriksson; Gunnar V Alm; Harald HH Goring; Tomi Pastinen; Ann-Christine Syvänen; Lars Rönnblom
A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5.
Human molecular genetics 2008;17(18):2868-76.
2008: Sergey V Kozyrev; Anna-Karin Abelson; Jerome Wojcik; Ammar Zaghlool; Mv Prasad Linga Reddy; Elena Sanchez; Iva Gunnarsson; Elisabet Svenungsson; Gunnar Sturfelt; Andreas Jönsen; Lennart Truedsson; Bernardo A Pons-Estel; Torsten Witte; Sandra D'Alfonso; Nadia Barrizzone; Maria Giovanna Danieli; Carmen Gutierrez; Ana Suarez; Peter Junker; Henrik K Laustrup; Maria Francisca González-Escribano; Javier Martin; Hadi Abderrahim; Marta E Alarcón-Riquelme
Corrigendum: Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus.
Nature genetics 2008;40(4):484.
2008: Snaevar Sigurdsson; Harald HH Goring; Gudlaug Kristjansdottir; Lili Milani; Gunnel Nordmark; Johanna K Sandling; Maija-Leena Eloranta; Di Feng; Niquiche Sangster-Guity; Iva Gunnarsson; Elisabet Svenungsson; Gunnar Sturfelt; Andreas Jönsen; Lennart Truedsson; Betsy J Barnes; Gunnar V Alm; Lars Rönnblom; Ann-Christine Syvänen
Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus.
Human molecular genetics 2008;17(6):872-81.
2008: T Jónsdóttir; Iva Gunnarsson; A Risselada; E W Henriksson; Lars Klareskog; Ronald van Vollenhoven
Treatment of refractory SLE with rituximab plus cyclophosphamide: clinical effects, serological changes, and predictors of response.
Annals of the rheumatic diseases 2008;67(3):330-4.
2008: Geoffrey Hom; Robert R Graham; Barmak Modrek; Kimberly E Taylor; Ward Ortmann; Sophie Garnier; Annette T Lee; Sharon A Chung; Ricardo C Ferreira; P V Krishna Pant; Dennis G Ballinger; Roman Kosoy; F Yesim Demirci; M Ilyas Kamboh; Amy H Kao; Chao Tian; Iva Gunnarsson; Anders A Bengtsson; Solbritt Rantapää-Dahlqvist; Michelle Petri; Susan Manzi; Michael F Seldin; Lars Rönnblom; Ann-Christine Syvänen; Lindsey A Criswell; Peter K Gregersen; timothy wayne behrens
Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX.
The New England journal of medicine 2008;358(9):900-9.
2008: Sergey V Kozyrev; Anna-Karin Abelson; Jerome Wojcik; Ammar Zaghlool; M V Prasad Linga Reddy; Elena Sanchez; Iva Gunnarsson; Elisabet Svenungsson; Gunnar Sturfelt; Andreas Jönsen; Lennart Truedsson; Bernardo A Pons-Estel; Torsten Witte; Sandra D'Alfonso; Nadia Barizzone; Nadia Barrizzone; Maria Giovanna Danieli; Carmen Gutierrez; Ana Suarez; Peter Junker; Henrik K Laustrup; María Francisca González-Escribano; Javier Martin; Hadi Abderrahim; Marta E Alarcón-Riquelme
Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus.
Nature genetics 2008;40(2):211-6.
2007: M V Prasad Linga-Reddy; Iva Gunnarsson; Elisabet Svenungsson; Gunnar Sturfelt; Andreas Jönsen; Lennart Truedsson; Gunnel Nordmark; Lars Rönnblom; Marta E Alarcón-Riquelme
A polymorphic variant in the MHC2TA gene is not associated with systemic lupus erythematosus.
Tissue antigens 2007;70(5):412-4.
2007: Elena Sánchez; Anna-Karin Abelson; José Mario Sabio; Miguel A González-Gay; Norberto Ortego Centeno; Juan Jiménez-Alonso; Enrique de Ramón; Julio Sánchez Román; Miguel A López-Nevot; Iva Gunnarsson; Elisabet Svenungsson; Gunnar Sturfelt; Lennart Truedsson; Andreas Jönsen; María Francisca González-Escribano; Torsten Witte; Marta E Alarcón-Riquelme; Javier Martín
Association of a CD24 gene polymorphism with susceptibility to systemic lupus erythematosus.
Arthritis and rheumatism 2007;56(9):3080-6.
2007: Andreas Jönsen; Iva Gunnarsson; Birgitta Gullstrand; Elisabet Svenungsson; Anders A Bengtsson; Ola Nived; Ingrid E Lundberg; Lennart Truedsson; Gunnar Sturfelt
Association between SLE nephritis and polymorphic variants of the CRP and FcgammaRIIIa genes.
Rheumatology (Oxford, England) 2007;46(9):1417-21.
2007: Robert R Graham; Chieko Kyogoku; Snaevar Sigurdsson; Irina Vlasova - St. Louis; Leela R L Davies; Emily C Baechler; Robert M Plenge; Thearith Koeuth; Ward A Ortmann; Geoffrey Hom; Jason W Bauer; Clarence Gillett; Noël P Burtt; Deborah S Cunninghame-Graham; Robert C Onofrio; Michelle Petri; Iva Gunnarsson; Elisabet Svenungsson; Lars Rönnblom; Gunnel Nordmark; Peter K Gregersen; Kathy Moser; Patrick M Gaffney; Lindsey A Criswell; Timothy J Vyse; Ann-Christine Syvänen; Paul R Bohjanen; Mark J Daly; timothy wayne behrens; David Altshuler
Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(16):6758-63.
2007: Iva Gunnarsson; Birgitta Sundelin; Thorunn Jónsdóttir; Stefan H Jacobson; Elisabet Welin Henriksson; Ronald van Vollenhoven
Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis.
Arthritis and rheumatism 2007;56(4):1263-72.
2007: A K Abelson; Cecilia M Johansson; Sergey V Kozyrev; Helga Kristjansdottir; Iva Gunnarsson; Elisabet Svenungsson; Andreas Jönsen; Guadalupe Lima; Hugo R Scherbarth; Susana Gamron; A Allievi; Simon A Palatnik; Alejandro Alvarellos; Sergio Paira; C Graf; C Guillerón; Luis Catoggio; C Prigione; C G Battagliotti; Guillermo A Berbotto; Mercedes A García; Carlos E Perandones; Lennart Truedsson; Kristjan Steinsson; Gunnar Sturfelt; Bernardo A Pons-Estel; Marta E Alarcón-Riquelme
No evidence of association between genetic variants of the PDCD1 ligands and SLE.
Genes and immunity 2007;8(1):69-74.
2007: Therese Vallerskog; Iva Gunnarsson; Mona Widhe; Anke Risselada; Lars Klareskog; Ronald van Vollenhoven; Vivianne Malmström; Christina Trollmo
Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE.
Clinical immunology (Orlando, Fla.) 2007;122(1):62-74.
2006: Duojia Cao; O Börjesson; P Larsson; A Rudin; Iva Gunnarsson; Lars Klareskog; Vivianne Malmström; Christina Trollmo
FOXP3 identifies regulatory CD25bright CD4+ T cells in rheumatic joints.
Scandinavian journal of immunology 2006;63(6):444-52.
2006: Stefan H Jacobson; Ronald van Vollenhoven; Iva Gunnarsson
Rituximab-induced long-term remission of membranous lupus nephritis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(6):1742-3.
2006: Gisela Orozco; Elena Sánchez; Luis Miguel Gómez; Miguel A González-Gay; Miguel A López-Nevot; Belén Torres; Norberto Ortego Centeno; Juan Jiménez-Alonso; Enrique de Ramón; Julio Sánchez Román; Juan-Manuel Anaya; Gunnar Sturfelt; Iva Gunnarsson; E Svennungsson; Marta E Alarcón-Riquelme; María Francisca González-Escribano; Javier Martín
Study of the role of functional variants of SLC22A4, RUNX1 and SUMO4 in systemic lupus erythematosus.
Annals of the rheumatic diseases 2006;65(6):791-5.
2006: Therese Vallerskog; Mikael Heimbürger; Iva Gunnarsson; Wei Zhou; Marie Wahren-Herlenius; Christina Trollmo; Vivianne Malmström
Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis.
Arthritis research & therapy 2006;8(6):R167.
2005: Ronald van Vollenhoven; Iva Gunnarsson
In lupus nephritis, the benefit of rituximab monotherapy, as opposed to rituximab plus cyclophosphamide combination therapy, remains uncertain: comment on the article by Sfikakis et al.
Arthritis and rheumatism 2005;52(12):4050-1; author reply 4051-2.
2005: M V Prasad Linga Reddy; M Johansson; Gunnar Sturfelt; Andreas Jönsen; Iva Gunnarsson; Elisabet Svenungsson; Solbritt Rantapää-Dahlqvist; Marta E Alarcón-Riquelme
The R620W C/T polymorphism of the gene PTPN22 is associated with SLE independently of the association of PDCD1.
Genes and immunity 2005;6(8):658-62.
2005: Johan Frostegård; Elisabet Svenungsson; Ruihua Wu; Iva Gunnarsson; Ingrid E Lundberg; Lars Klareskog; Sohvi Hörkkö; Joseph L Witztum
Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations.
Arthritis and rheumatism 2005;52(1):192-200.
2004: Veronica Magnusson; Renata Zunec; J Odeberg; Gunnar Sturfelt; Lennart Truedsson; Iva Gunnarsson; Marta E Alarcón-Riquelme
Polymorphisms of the Fc gamma receptor type IIB gene are not associated with systemic lupus erythematosus in the Swedish population.
Arthritis and rheumatism 2004;50(4):1348-50.
2004: Ronald van Vollenhoven; Iva Gunnarsson; E Welin-Henriksson; Birgitta Sundelin; A Osterborg; Stefan H Jacobson; Lars Klareskog
Biopsy-verified response of severe lupus nephritis to treatment with rituximab (anti-CD20 monoclonal antibody) plus cyclophosphamide after biopsy-documented failure to respond to cyclophosphamide alone.
Scandinavian journal of rheumatology 2004;33(6):423-7.
2004: Ludmila Prokunina-Olsson; Iva Gunnarsson; Gunnar Sturfelt; Lennart Truedsson; Victoria A Seligman; Jean L Olson; Michael F Seldin; Lindsey A Criswell; Marta E Alarcón-Riquelme
The systemic lupus erythematosus-associated PDCD1 polymorphism PD1.3A in lupus nephritis.
Arthritis and rheumatism 2004;50(1):327-8.
2003: Elisabet Svenungsson; Iva Gunnarsson; Guo-Zhong Fei; Ingrid E Lundberg; Lars Klareskog; Johan Frostegård
Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus.
Arthritis and rheumatism 2003;48(9):2533-40.
2002: Ludmila Prokunina-Olsson; Casimiro Castillejo-López; Fredrik Oberg; Iva Gunnarsson; Louise Berg; Veronica Magnusson; Anthony J Brookes; Dmitry Tentler; Helga Kristjansdóttir; Gerdur Gröndal; Anne Isine Bolstad; Elisabet Svenungsson; Ingrid Lundberg; Gunnar Sturfelt; Andreas Jönssen; Lennart Truedsson; Guadalupe Lima; Jorge Alcocer-Varela; Roland Jonsson; Ulf Gyllensten; John B Harley; Donato Alarcón-Segovia; Kristjan Steinsson; Marta E Alarcón-Riquelme
A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans.
Nature genetics 2002;32(4):666-9.
2002: Iva Gunnarsson; Birgitta Sundelin; Mikael Heimbürger; Jan Forslid; Ronald van Vollenhoven; Ingrid Lundberg; Stefan H Jacobson
Repeated renal biopsy in proliferative lupus nephritis--predictive role of serum C1q and albuminuria.
The Journal of rheumatology 2002;29(4):693-9.
2001: Iva Gunnarsson; B Ringertz; J Bratt; Birgitta Sundelin
HLA-DRB1*0301 and DQA1*0501 in RA.
Annals of the rheumatic diseases 2001;60(7):727.
2001: Adla B Hassan; Iva Gunnarsson; Göran Karlsson; Lars Klareskog; Jan Forslid; Ingrid E Lundberg
Longitudinal study of interleukin-10, tumor necrosis factor-alpha, anti-U1-snRNP antibody levels and disease activity in patients with mixed connective tissue disease.
Scandinavian journal of rheumatology 2001;30(5):282-9.
2000: Veronica Magnusson; Anna-Karin B Lindqvist; Casimiro Castillejo-López; H Kristjánsdottir; Kristjan Steinsson; Gerdur Gröndal; Gunnar Sturfelt; Lennart Truedsson; Elisabet Svenungsson; Ingrid Lundberg; Iva Gunnarsson; Anne Isine Bolstad; Hans-Jacob Haga; Roland Jonsson; Lars Klareskog; Jorge Alcocer-Varela; Donato Alarcón-Segovia; Joseph D Terwilliger; Ulf Gyllensten; Marta E Alarcón-Riquelme
Fine mapping of the SLEB2 locus involved in susceptibility to systemic lupus erythematosus.
Genomics 2000;70(3):307-14.
2000: Gerdur Gröndal; Iva Gunnarsson; Johan Rönnelid; Siv Rogberg; Lars Klareskog; Ingrid Lundberg
Cytokine production, serum levels and disease activity in systemic lupus erythematosus.
Clinical and experimental rheumatology 2000;18(5):565-70.
2000: C Johansson; Casimiro Castillejo-López; Bo Johanneson; Elisabet Svenungsson; Iva Gunnarsson; J Frostegård; Gunnar Sturfelt; Lennart Truedsson; B Löfström; Jorge Alcocer-Varela; Ingrid Lundberg; Ulf Gyllensten; Donato Alarcón-Segovia; Marta E Alarcón-Riquelme
Association analysis with microsatellite and SNP markers does not support the involvement of BCL-2 in systemic lupus erythematosus in Mexican and Swedish patients and their families.
Genes and immunity 2000;1(6):380-5.
2000: Iva Gunnarsson; B Nordmark; A Hassan Bakri; Gerdur Gröndal; P Larsson; Jan Forslid; Lars Klareskog; B Ringertz
Development of lupus-related side-effects in patients with early RA during sulphasalazine treatment-the role of IL-10 and HLA.
Rheumatology (Oxford, England) 2000;39(8):886-93.
1999: Nader Pourmand; Marie Wahren-Herlenius; Iva Gunnarsson; Elisabet Svenungsson; B Löfström; Y Ioannou; D A Isenberg; C G Magnusson
Ro/SSA and La/SSB specific IgA autoantibodies in serum of patients with Sjögren's syndrome and systemic lupus erythematosus.
Annals of the rheumatic diseases 1999;58(10):623-9.
1999: Ruihua Wu; Elisabet Svenungsson; Iva Gunnarsson; C Haegerstrand-Gillis; B Andersson; I Lundberg; LS Elinder; Johan Frostegård
Antibodies to adult human endothelial cells cross-react with oxidized low-density lipoprotein and beta 2-glycoprotein I (beta 2-GPI) in systemic lupus erythematosus.
Clinical and experimental immunology 1999;115(3):561-6.
1999: Iva Gunnarsson; Jan Forslid; B Ringertz
Mesalazine-induced lupus syndrome.
Lupus 1999;8(6):486-8.
1999: Ruihua Wu; Elisabet Svenungsson; Iva Gunnarsson; B Andersson; I Lundberg; L Schäfer-Elinder; Johan Frostegård
Antibodies against lysophosphatidylcholine and oxidized LDL in patients with SLE.
Lupus 1999;8(2):142-50.
1998: A Bakri Hassan; Johan Rönnelid; Iva Gunnarsson; Göran Karlsson; Louise Berg; Ingrid Lundberg
Increased serum levels of immunoglobulins, C-reactive protein, type 1 and type 2 cytokines in patients with mixed connective tissue disease.
Journal of autoimmunity 1998;11(5):503-8.
1997: Iva Gunnarsson; Johan Rönnelid; Ingrid Lundberg; Stefan H Jacobson
Occurrence of anti-C1q antibodies in IgA nephropathy.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1997;12(11):2263-8.
1997: Iva Gunnarsson; L Kanerud; E Pettersson; Ingrid Lundberg; Staffan Lindblad; B Ringertz
Predisposing factors in sulphasalazine-induced systemic lupus erythematosus.
British journal of rheumatology 1997;36(10):1089-94.
1997: Johan Rönnelid; Iva Gunnarsson; Kristina Nilsson-Ekdahl; Bo Nilsson
Correlation between anti-C1q and immune conglutinin levels, but not between levels of antibodies to the structurally related autoantigens C1q and type II collagen in SLE or RA.
Journal of autoimmunity 1997;10(4):415-23.
1997: Iva Gunnarsson; Johan Rönnelid; Jenny Huang; Siv Rogberg; B Nilsson; Ingrid Lundberg; Lars Klareskog
Association between ongoing anti-C1q antibody production in peripheral blood and proliferative nephritis in patients with active systemic lupus erythematosus.
British journal of rheumatology 1997;36(1):32-7.
1997: Iva Gunnarsson; E Pettersson; Staffan Lindblad; B Ringertz
Olsalazine-induced lupus syndrome.
Scandinavian journal of rheumatology 1997;26(1):65-6.
1994: Iva Gunnarsson; G Lindahl; E Hedfors
[A dreaded complication. Permanent loss of vision in temporal arteritis].
Läkartidningen 1994;91(35):3049-52.